Sort
34,240 grants matching “atherosclerosis”
Anti-atherogenic Mechanisms of the Dual Rho-GEF Kalirin
$466,046Neil J. Freedman · Duke University · R01 · FY2015 · HL
MALDI TOF/TOF Mass Spectrometer for Imaging Thin Tissue Sections
$466,012Joseph A Loo · University Of California Los Angeles · S10 · FY2010 · RR
Role of Toll-Like Receptors in Atherogenesis
$466,000Linda K Curtiss · University Of California, San Diego · P01 · FY2010 · HL
Toll Receptors in Atherosclerosis
$466,000Linda K Curtiss · Scripps Research Institute, The · R01 · FY2007 · HL
Role of Toll-Like Receptors in Atherogenesis
$466,000Linda K Curtiss · University Of California, San Diego · P01 · FY2009 · HL
Proteomic Analysis of Plasminogen Receptors
$466,000Lindsey A Miles · Scripps Research Institute, The · R01 · FY2007 · HL
Pathways of Oxidation of HDL by Macrophages
$465,921Jay W Heinecke · University Of Washington · P01 · FY2009 · HL
Age-Associated Changes in Arterial Proteome and Aortic Smooth Muscle Signaling
$465,919Edward Lakatta · National Institute On Aging · ZIA · FY2017 · AG
Effects of Aging on Experimental Atherosclerosis in Nonhuman Primates
$465,919Edward Lakatta · National Institute On Aging · ZIA · FY2017 · AG
Nuclear FAK-mediated VSMC differentiation via epigenetic reprograming invascular diseases
$465,910Steve Lim · University Of Alabama At Birmingham · R01 · FY2024 · HL
Basic Research on Hematopoietic Human Stem Cells
$465,906Harry L Malech · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
VISCERAL FAT, METABOLIC RATE AND CVD IN YOUNG ADULTS
$465,857Kaiser Foundation Hospitals · R01 · FY2001 · HL
Functional genomics of GxE in cardiovascular disease: BPA, phthalates and their interactions with gene regulation
$465,833Francesca Luca · University Of Chicago · R01 · FY2025 · ES
Genome-Wide Association of Platelet Phenotypes
$465,811Lewis C Becker · Johns Hopkins University · R01 · FY2009 · HL
Targeting a Ceramide Double Bond to Treat Cardiometabolic Disorders
$465,796Scott A Summers · University Of Utah · R01 · FY2020 · DK
Targeting a Ceramide Double Bond to Treat Cardiometabolic Disorders
$465,796Scott A Summers · University Of Utah · R01 · FY2021 · DK
Targeting a Ceramide Double Bond to Treat Cardiometabolic Disorders
$465,796Scott A Summers · University Of Utah · R01 · FY2022 · DK
Transforming Growth Factor Betal and Arterial Disease
$465,782University Of Washington · R01 · FY2005 · HL
ATHEROSCLEROSIS AND PERIPHERAL APOPROTEIN E SYNTHESIS
$465,743State University New York Stony Brook · R01 · FY2000 · HL
Characterization of Atherosclerosis Modifier Genes
$465,718Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · R01 · FY2010 · HL
HDL receptor SR-BI and a model of coronary heart disease
$465,679Massachusetts Institute Of Technology · P01 · FY2005 · HL
Optimizing bone surface targeting of therapeutic antibodies for osteoporosis
$465,663Colin Fred Greineder · University Of Michigan At Ann Arbor · R01 · FY2025 · AR
SCAVENGER RECEPTOR B1 IN CELLULAR CHOLESTEROL METABOLISM
$465,620State University New York Stony Brook · R01 · FY2002 · HL
Mechanisms regulating apoptotic cell clearance in health and disease
$465,573Kodi S Ravichandran · University Of Virginia · R35 · FY2019 · GM
Mechanisms regulating apoptotic cell clearance in health and disease
$465,573Kodi S Ravichandran · University Of Virginia · R35 · FY2020 · GM